Edwards Lifesciences (EW) Change in Acquisitions & Divestments (2009 - 2026)

Edwards Lifesciences' Change in Acquisitions & Divestments history runs 17 years deep, the most recent figure standing at $710.1 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments rose 3911.86% year-over-year to $710.1 million; the TTM figure through Mar 2026 stood at $754.5 million (up 1019.0% YoY), while the FY2025 annual figure was $62.1 million, up 8.0% from the prior year.
• Change in Acquisitions & Divestments was $710.1 million for Q1 2026 at Edwards Lifesciences, up from -$2.0 billion in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $2.1 billion in Q3 2025 to a low of -$2.0 billion in Q4 2025.
• Historically, Change in Acquisitions & Divestments has averaged $109.8 million across 5 years, with a median of $80.5 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Change in Acquisitions & Divestments jumped 7603.33% in 2024, then tumbled 325.1% in 2025.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $921.6 million in 2022, then plunged by 142.21% to -$389.0 million in 2023, then decreased by 23.8% to -$481.6 million in 2024, then plunged by 325.1% to -$2.0 billion in 2025, then surged by 134.68% to $710.1 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $710.1 million (Q1 2026), -$2.0 billion (Q4 2025), and $2.1 billion (Q3 2025), per Business Quant data.